About this trial
The primary goal of this project is to describe the clinical and physiologic characteristics of Spontaneous Coronary Artery Dissections (SCAD) in order to increase awareness, understanding, treatment and prevention of a potentially fatal cardiovascular event.
This study will be a retrospective and prospective review of medical course and current health of men and women with SCAD.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Individuals who have been cared for at Mayo Clinic with a diagnosis of SCAD
SCAD in women who are pregnant or within 12 months postpartum at the time of SCAD
SCAD in individuals who self-identify as a member of a racial or ethnic group that is currently underrepresented in the registry. This would include anyone who identifies as: Black/African American, Asian, American Indian or Alaska Native, Native Hawaiian or Other Pacific Islander, and any race with Hispanic ethnicity
SCAD in a man
Disqualifiers
None
Trial population
Men and women with spontaneous coronary artery dissection (SCAD) as confirmed on angiogram.
Trial design
Cohort
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Descriptive Data
Obtain data regarding SCAD related risk factors, presenting characteristics, treatments and long term outcomes.
Secondary outcomes
Physical Health Update
Record update on patient's current physical health and any relevant health events that may have occurred since the initial SCAD event.
Mental Health Update
Record update on patient's current mental health status since the initial SCAD event.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.